New vaccine support (NVS) for MEASLESFU

GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems.

ID Projet
47122-18-LBR-36A-X
Statut de l'activité
2 - Implementation
Type d'aide
B02 - Contributions aux budgets réguliers des institutions multilatérales
% to Libéria
100.00

Organisations

Funding
The Global Alliance for Vaccination and Immunisation
Extending
World Health Organisation - core voluntary contributions account (for technical assitance)
Accountable
Federal States & Local Governments
Implementing
Federal States & Local Governments
Extending
United Nations Childrens Fund

Versements par exercice fiscal, trimestre

Exercice fiscal Trimestre fiscal Montant (USD) Libéria Montant (USD)
2017 Q3 -22,199.00 -22,199.00
2017 Q1 258,221.00 258,221.00

Engagements par exercice fiscal, trimestre

Exercice fiscal Trimestre fiscal Montant (USD) Libéria Montant (USD)
2017 Q3 -12,478.00 -12,478.00
2017 Q1 248,500.00 248,500.00

Projections de CDMT par exercice fiscal

Exercice fiscal Montant (USD) Libéria Montant (USD)
2018 124,250.00 124,250.00
2017 124,250.00 124,250.00

Code CRS %
Lutte contre les maladies infectieuses (12250) 100.0